Literature DB >> 15681626

Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects.

Alicia Osimani1, Andrea Berger, Joshua Friedman, Bat-Sheba Porat-Katz, Jacob M Abarbanel.   

Abstract

Cobalamin deficiency may cause cognitive deficits and even dementia. In Alzheimer's disease, the most frequent cause of dementia in elderly persons, low serum levels of vitamin B12, may be misleading. The aim of this work was to characterize the cognitive pattern of B12 deficiency and to compare it with that of Alzheimer's disease. Nineteen patients with low levels of vitamin B12 were neuropsychologically evaluated before treatment and a year later. Results were compared with those of 10 healthy control subjects. Final results suggest that there is a different pattern in both diseases. Twelve elderly patients with dementia improved with treatment. Seven elderly demented patients did not improve; they deteriorated after 1 year although their levels of cobalamin were normal. Analysis of the initial evaluation showed that the 2 groups of patients had a different neuropsychological profile. The group that improved had initially more psychotic problems and more deficits in concentration, visuospatial performance, and executive functions. They did not show language problems and ideomotor apraxia, which were present in the second group. Their memory pattern was also different. These findings suggest that cobalamin deficiency may cause a reversible dementia in elderly patients. This dementia may be differentiated from that of Alzheimer's disease by a thorough neuropsychological evaluation.

Entities:  

Mesh:

Year:  2005        PMID: 15681626     DOI: 10.1177/0891988704272308

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  12 in total

1.  Vitamin B12 deficiency associated with symptoms of frontotemporal dementia.

Authors:  C Blundo; D Marin; M Ricci
Journal:  Neurol Sci       Date:  2010-10-07       Impact factor: 3.307

2.  Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.

Authors:  Pasquale Mansueto; Laura Di Stefano; Alberto D'Alcamo; Antonio Carroccio
Journal:  BMJ Case Rep       Date:  2012-07-04

Review 3.  Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs.

Authors:  Gifty M Jojo; Gowthamarajan Kuppusamy; Kousalya Selvaraj; Uday Krishna Baruah
Journal:  J Diabetes Metab Disord       Date:  2019-05-09

4.  Cobalamin deficiency in the elderly: aetiology and management: a study of 125 patients in a geriatric hospital.

Authors:  A-L Couderc; J Camalet; S Schneider; J M Turpin; I Bereder; R Boulahssass; S Gonfrier; P Bayer; O Guerin; P Brocker
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

5.  Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's Disease.

Authors:  Shu-Mei Chen; Tsung-Chin Hsu; Chee-Ho Chew; Wan-Ting Huang; Amanda Lin Chen; Yung-Feng Lin; Sabiha Eddarkaoui; Luc Buee; Chien-Chung Chen
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.

Authors:  Maire E Percy; Walter J Lukiw
Journal:  Int J Dev Disabil       Date:  2017-04-09

8.  Do MCI patients with vitamin B12 deficiency have distinctive cognitive deficits?

Authors:  Dina Silva; Ulrike Albers; Isabel Santana; Margarida Vicente; Isabel Pavão Martins; Ana Verdelho; Manuela Guerreiro; Alexandre de-Mendonça
Journal:  BMC Res Notes       Date:  2013-09-08

9.  Carotenoid-Rich Brain Nutrient Pattern Is Positively Correlated With Higher Cognition and Lower Depression in the Oldest Old With No Dementia.

Authors:  Jirayu Tanprasertsuk; Tammy M Scott; Aron K Barbey; Kathryn Barger; Xiang-Dong Wang; Mary Ann Johnson; Leonard W Poon; Rohini Vishwanathan; Nirupa R Matthan; Alice H Lichtenstein; Guylaine Ferland; Elizabeth J Johnson
Journal:  Front Nutr       Date:  2021-06-29

Review 10.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.